vimarsana.com
Home
Live Updates
Gimv : ImCheck to Present New Positive Data on ICT01 Monothe
Gimv : ImCheck to Present New Positive Data on ICT01 Monothe
Gimv : ImCheck to Present New Positive Data on ICT01 Monotherapy in Hematological Cancers at ESMO 2023 -October 19, 2023 at 02:27 am EDT
Interim data from Phase I dose escalation portion of EVICTION Phase I/IIa trial show strong safety profile and encouraging clinical activity for ICT01 monotherapy in relapsed/refractory...
Related Keywords
Madrid ,
Spain ,
Institut Paoli Calmettes ,
Sylvain Garciaz ,
European Society For Medical Oncology ,
Department Of Hematology ,
Imcheck Therapeutics ,
European Society ,
Medical Oncology ,
Refractory Hematologic Cancers ,
Acute Myeloid Leukemia ,
Markets ,